D. Benitez, M. Cabrera, P. Hernández, L. Boiani, M. L. Lavaggi, R. Di Maio, G. Yaluff, E. Serna, S. Torres, M. E. Ferreira, N. Vera de Bilbao, E. Torres, S. Pérez-Silanes, B. Solano, E. Moreno, I. Aldana, A. López de Ceráin, H. Cerecetto, M. González and A. Monge, “Trifluoromethylquinoxaline N,N'-dioxides as Anti-Trypanosomatid Agents. Identification of Optimal Anti-T. Cruzi Agents and Mechanism of Action Studies,” Journal of Medicinal Chemistry, Vol. 54, No. 10, 2011, pp. 3624-3636.
http://dx.doi.org/10.1021/jm2002469

has been cited by the following article:

• TITLE: Synthesis, Characterization, Anti-Bacterial and Anti-Fungal Activities of New Quinoxaline 1,4-di-N-Oxide Derivatives

  AUTHORS: Dalia Hussein Soliman

  KEYWORDS: Quinoxaline 1, 4-di-N-Oxide; Beirut Reaction; Benzofuroxanes; β-Ketoamide; β-Cyanoamide; Antibacterial; Antifungal

  JOURNAL NAME: International Journal of Organic Chemistry, Vol.3 No.3A, November 28, 2013

  ABSTRACT: A new series of quinoxaline 1,4-di-N-oxides were synthesized and evaluated for their antibacterial and antifungal activities. The best result was demonstrated by 3-amino-N-(4-methoxyphenyl)-2-quinoxalinecarboxamide 1,4-di-N-oxide 4e, MIC (0.24 μg/ml) against Aspergillus fumigatus, and (0.12 μg/ml) against Streptococcus pneumonia.